Hiring a VP of Regulatory Affairs for Global Pharma Companies

Having placed leaders into roles like this repeatedly, we wrote this to give a practitioner’s view rather than generic advice. A VP of Regulatory Affairs in a global pharmaceutical company must manage submissions and lifecycle obligations across jurisdictions whose requirements, timelines, and expectations differ substantially, while maintaining a coherent global strategy. The core capability is not knowing every regional requirement but knowing how to build a global strategy that does not collapse when regions diverge.

Key Takeaways

  • Global regulatory strategy must accommodate genuine regional divergence.
  • Depth in your priority markets matters more than superficial global breadth.
  • Agency relationship skill materially affects outcomes.
  • Lifecycle management is as consequential as initial approval.
  • Assess how the candidate handled a regulatory setback.

Global Strategy That Survives Regional Divergence

Regulatory requirements differ meaningfully across major jurisdictions in evidence expectations, procedural mechanics, timelines, and how agencies interpret data. A global VP must build a strategy that produces a coherent dossier and sequence while accommodating these differences, rather than assuming a single approach travels. The distinguishing capability is judgment about where to converge and where to accept divergence, whether to run additional studies for a particular region, how to sequence filings, when regional requirements should shape global development. Assess this reasoning specifically, since it is where global regulatory leadership is genuinely tested.

Depth Where It Matters Most

Candidates often present broad international exposure, but depth in your specific priority markets usually matters more than breadth. A company whose value depends on US and European approval needs genuine depth in those systems and the relationships that come with it, more than familiarity with a dozen smaller markets. Identify which jurisdictions actually determine your commercial outcome and weight experience there accordingly, treating wider exposure as useful but secondary. This focuses the search on a more relevant, and often smaller, candidate pool.

Agency Engagement Is a Skill

How a company engages with regulators, in scientific advice meetings, in responses to questions, in managing disagreement, materially affects timelines and outcomes. This is a genuine skill: knowing what to ask, how to frame a position, when to concede and when to argue, and how to build institutional credibility over repeated interactions. Ask candidates to describe specific agency interactions, particularly difficult ones, and listen for whether they treat the relationship strategically or transactionally. Regulators remember companies, and a VP who has built credibility is carrying an asset.

Lifecycle Management and Setbacks

Initial approval is a fraction of the regulatory workload; variations, renewals, safety-related label changes, post-approval commitments, and manufacturing changes continue for the product’s life and carry real risk if mishandled. Assess lifecycle experience explicitly rather than focusing only on approvals. Equally, ask about a regulatory setback, a refusal, a major objection, an unexpected question that delayed a programme, and how the candidate responded. Almost every experienced regulatory leader has one, and how they handled it reveals more than their approval record does.

What This Looks Like in Practice

A global pharmaceutical company hiring a VP of Regulatory Affairs assesses reasoning about where to converge and diverge across jurisdictions, weights depth in its commercially decisive markets over broad international familiarity, probes specific agency interactions including difficult ones, and examines lifecycle management experience and how the candidate handled a genuine regulatory setback.

The Mistake Employers Keep Making

The most common mistake is treating global regulatory experience as a single credential, hiring someone with exposure to many markets but genuine depth in none of the ones that determine the company’s commercial outcome. The candidate can describe every system in general terms and lacks the specific judgment and agency credibility that matter where it counts. Breadth is mistaken for depth.

What to Weight in a Global Regulatory VP

Factor Why It Matters
Depth in decisive markets Determines commercial outcome
Convergence and divergence judgment Global strategy must survive regional difference
Agency relationship skill Materially affects timelines and outcomes
Lifecycle experience Most regulatory work follows approval
Response to a setback More revealing than an approval record

The Bottom Line

A global regulatory VP must build strategy that survives genuine regional divergence, bring real depth in the markets that determine your commercial outcome, engage agencies with strategic skill, and manage the lifecycle obligations that constitute most regulatory work, so weight depth and judgment over broad international familiarity. The employers who hire well here are the ones who respect what makes the role specific, and search accordingly.

For more, see How to Hire a Head of Pharmacovigilance, How to Recruit a Chief Medical Officer for a Pharma Company, Succession Planning for Aging Pharma Leadership.

Frequently Asked Questions

Q: What is the core capability of a global regulatory VP?
A: Building a global strategy that accommodates genuine regional divergence in evidence expectations, procedures, and timelines, rather than assuming one approach travels across jurisdictions.
Q: Is broad international experience the priority?
A: Usually not; depth in the jurisdictions that determine your commercial outcome matters more than familiarity with many smaller markets.
Q: Why does agency engagement skill matter?
A: Because how a company frames positions, responds to questions, and manages disagreement materially affects timelines and outcomes, and credibility accumulates across repeated interactions.
Q: Should I assess lifecycle experience?
A: Yes; variations, renewals, label changes, post-approval commitments, and manufacturing changes constitute most regulatory work and carry real risk if mishandled.
Q: What question is most revealing?
A: Asking about a regulatory setback and how they responded, since almost every experienced leader has one and the handling reveals more than an approval record.

Tanya Gallardo

Managing Director, Executive Search & AI Talent Strategy

Tanya Gallardo is the Managing Director of Executive Search & AI Talent Strategy at JRG Partners, leading C-suite and Board engagements across key growth sectors including Technology, Financial Services, and Manufacturing.

With over 18 years of experience specializing in disruptive technology leadership, Tanya is recognized as a leading authority on talent architecture for future-focused executive roles, such as the Chief AI Officer (CAIO) and Chief Digital Officer (CDO). Her expertise lies in accurately assessing the cultural fit and technical depth required to ensure a high return on investment (ROI) for critical leadership appointments.

Prior to her role at JRG Partners, Tanya held senior roles directing global talent acquisition strategies at a major publicly-traded technology firm, advising on organizational design and succession planning for emerging executive functions. She is a recognized speaker and contributor to industry events, sharing data-driven insights on executive compensation, leadership development, and the measurable business impact of C-suite talent.

Connect with Tanya to discuss your executive search needs.

Leave a Reply

Your email address will not be published. Required fields are marked *